BioSpace News Archive

Business

DiaCarta and MIODx Join Forces to Develop a Diagnostic Test to Predict Patient Responses to Immunotherapy

The test is based on MIODx’s ClonoMap™ immune sequencing platform, and is designed to predict patient response to immunotherapy.

April 16, 2018

·

2 min read

Drug Development

Deciphera Pharmaceuticals, Inc. Reports Updated Data from Ongoing Phase 1 Clinical Trial of DCC-2618 at 2018 American Association for Cancer Research (AACR) Annual Meeting

Pharmacokinetic (PK), Safety, and Tolerability Profile of DCC-2618 in a Phase 1 Clinical Trial Supports 150mg QD Selected for a Pivotal Phase 3 Study in Gastrointestinal Stromal Tumor (GIST)

April 16, 2018

·

7 min read

Genetown

X4 Pharmaceuticals Presents Clinical Data Demonstrating Single Agent X4P-001-IO Enhances Tumor Immunity

Clinical data demonstrate single agent X4P-001-IO increases immune cell infiltration and activation in the tumor microenvironment (TME)

April 16, 2018

·

4 min read

Predicine Closes Series A Financing Totaling $13.5M

Predicine provides an integrated oncology biomarker solution that includes an innovative RNA+DNA liquid biopsy test and a one-stop biomarker and data analysis platform to support targeted cancer therapeutics and global clinical trials.

April 16, 2018

·

2 min read

Business

Enclara Pharmacia Announces Strategic Partnership with Medline, Expands E3 Mobile Clinical Management Platform, Advances Integration of Essential Clinical Services

Enclara team presents full demo of pharmacy, DME and medical supply services at NHPCO MLC conference

April 16, 2018

·

3 min read

Policy

MediMergent and FDA Launch New Stakeholder Initiative against Medication Non-Adherence/Persistence Crisis

There are approximately 117 million Americans who have chronic diseases requiring lifelong medications; the non-adherence rate to their medicine by six months post initiation of therapy is approximately 50%.

April 16, 2018

·

4 min read

Biotech Bay

AcelRx Announces Completion of the Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 2018

This study was recommended by the FDA following the Company’s application of FDA recommended changes to the DSUVIA DFU to ensure the safe and proper administration of DSUVIA to patients by healthcare professionals in medically supervised settings.

April 16, 2018

·

3 min read

Policy

Navidea Signs Deal to Sublicense NAV4694 Worldwide Development Rights

NAV4694 is a beta-amyloid imaging agent being evaluated as an aid in the differential diagnosis of early-onset Alzheimer’s disease

April 16, 2018

·

3 min read

Business

Kineta to Collaborate on the Development of a Novel Non-Opioid Pain Therapy with Genentech

Collaboration to develop a first-in-class α9/α10 nicotinic acetylcholine receptor antagonist for the treatment of chronic pain

April 16, 2018

·

3 min read

Drug Development

Tocagen Presents Preliminary Toca 6 Phase 1 Data in Patients with Advanced Solid Tumors at the American Association for Cancer Research (AACR) Annual Meeting 2018

Safety, tolerability, confirmation of vector deposition demonstrated with intravenous delivery of Toca 511

April 16, 2018

·

5 min read